Expression of hepatocyte growth factor, transforming growth factor α, and transforming growth factor β1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation

Hepatology

Volumn 24, Issue 2, 1996, Pages 323-329

  Masuhara, Masaaki ^a,b   Yasunaga, Mitsuru ^a   Tanigawa, Koji ^a   Tamura, Fusako ^a   Yamashita, Satoyoshi ^a   Sakaida, Isao ^a   Okita, Kiwamu ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE HEPATITIS; ARTICLE; CELL PROLIFERATION; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER INJURY; PRIORITY JOURNAL;

EID: 0029783407     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008690400     Document Type: Article

References (41)

1. Kayano K, Yasunaga M, Kubota M, Takenaka K, Mori K, Yamashita A, Kubo Y, et al. Detection of proliferating hepatocytes by immunohistochemical staining for proliferating cell nuclear antigen (PCNA) in patients with acute hepatic failure. Liver 1992;12:132-136.
2. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122:1450-1459.
3. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci U S A 1986;83:6489-6493.
4. Zarnegar R, Michalopoulos GK. Purification and biological characterization of human hepatopoietin A, a peptide growth factor for hepatocytes. Cancer Res 1989;49:3314-3320.
5. Gohda E, Tsubouchi H, Nakayama H, Hirono H, Sakiyama O, Takahashi K, Miyazaki H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988;81:414-419.
6. Kinoshita T, Tashiro K, Nakamura T. Marked increase of HGF mRNA in nonparenchymal liver cells of rats treated with hepatotoxin. Biochem Biophys Res Commun 1989;165:1229-1234.
7. Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S, Nakamura T. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers as revealed by in situ hybridization. Biochem Biophys Res Commun 1990;173:42-47.
8. Lindroos P, Zarnegar R, Michalopoulos G. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. HEPATOLOGY 1991;13:743-750.
9. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo, HEPATOLOGY 1992;16: 1227-1235.
10. Webber EM, Godowski PJ, Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. HEPATOLOGY 1994; 19:489-497.
11. Shiota G, Wang CT, Nakamura T, Schmidt EV. Hepatocyte growth factor in transgenic mice: Effects on hepatocyte growth, liver regeneration and gene expression. HEPATOLOGY 1994;19:962-972.
12. Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S, Nakamura T. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers as revealed by in situ hybridization. Biochem Biophys Res Commun 1990;173:42-47.
13. Schirmacher P, Geerts A, Pietangelo A, Dienes HP, Roger CE. Hepatocyte growth factor/hepatopoietin A is expressed in fat storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. HEPATOLOGY 1992;15:5-11.
14. Kono S, Nagaike M, Matsumoto K, Nakamura T. Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury of distant organs. Biochem Biophys Res Commun 1992;186:991-998.
15. Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun 1992;182:802-809.
16. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. HEPATOLOGY 1995;21:106-112.
17. Delarco JE, Todaro GJ. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci U S A 1978;75:4001-4005.
18. Massague J. Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. J Biol Chem 1983;258:13614-13620.
19. Derynck R, Roberts AB, Winkler ME, Chen EY, Goeddel DV. Human transforming growth factor-α: precursor structure and expression in E. coli. Cell 1984;38:287-297.
20. Marquardt H, Hunkapiller MW, Hood LE, Todaro GJ. Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science 1984;223:1079-1082.
21. Mead JE, Fausto N. Transforming growth factor a may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci U S A 1989;86:1558-1562.
22. Johnson AC, Garfield SH, Merlino GT, Pastan I. Expression of epidermal growth factor receptor proto-oncogene mRNA in regenerating rat liver. Biochem Biophys Res Commun 1988;150:412-418.
23. Webber EM, Fitzgerald MJ, Brown PI, Bartlett MH, Fausto N. Transforming growth factor-α expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-α and hepatocyte growth factor. HEPATOLOGY 1993; 18:1422-1431.
24. Tomiya T, Fujiwara K. Serum levels of transforming growth factor-α in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay. HEPATOLOGY 1993;18:304-308.
25. Nakamura T, Tomita Y, Hirai R, Yamaoka K, Kaji K, Ichihara A. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 1985;133: 1042-1050.
26. Carr BI, Hayashi I, Branum EL, Moses HL. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor. Cancer Res 1986;46:2330-2334.
27. Russel WE. Transforming growth factor beta (TGF-β) inhibits hepatocyte DNA synthesis independently of EGF binding and EGF receptor autophosphorylation. J Cell Physiol 1988;135:253-261.
28. Russel WE, Coffey RJ, Ouellette AJ, Moses HL. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A 1988;85:5126-5130.
29. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N. Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci U S A 1988;85:1539-1543.
30. Takasaki Y, Deng JS, Tan EM. A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 1981;154:1899-1909.
31. Cellis JE, Celis A. Cell cycle dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells. Proc Natl Acad Sci U S A 1985;82:3262-3266.
32. Bravo R, Macdonald-Bravo H. Changes in the nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication. EMBO J 1985; 4:655-661.
33. Tsubouchi H, Nitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, et al. Levels of the human hepatocyte growth factor in serum of patients with various liver disease determined by an enzyme-linked immunosorbent assay. HEPATOLOGY 1991;13:1-5.
34. Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci U S A 1989;86:9717-9721.
35. Li B, Sehajpal PK, Khanna A, Vlassara H, Cerami A, Stenzel KH, Suthanthiran M. Differential regulation of transforming growth factor β and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med 1991;174:1259-1262.
36. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
37. Yasui W, Ji Z, Kuniyasu H, Ayhan Ayse, Yokozaki H, Ito H, Tahara E. Expression of transforming growth factor alpha in human tissues: immunohistochemical study and Northern blot analysis. Virchows Arch Pathol Anat 1992;421:513-519.
38. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J Cell Biol 1988;106:1659-1665.
39. Moustakas A, Lin HY, Henis YI, Plamondon J, O'Connor-McCourt MD, Lodish HF. The transforming growth factor β receptors type I, II, and III form hetero-oligomeric complexes in the presence of ligand. J Biol Chem 1993;268:22215-22218.
40. Chen RH, Ebmer R, Derynck R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 1993;260: 1335-1338.
41. Ebner R, Chen RH, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, et al. Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 1993;260:1344-1348.